Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 290

1.

MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.

Cui M, Wang Y, Sun B, Xiao Z, Ye L, Zhang X.

Biochem Biophys Res Commun. 2014 Feb 7;444(2):270-5. doi: 10.1016/j.bbrc.2014.01.051. Epub 2014 Jan 22.

PMID:
24462768
2.

Involvement of cholesterol in hepatitis B virus X protein-induced abnormal lipid metabolism of hepatoma cells via up-regulating miR-205-targeted ACSL4.

Cui M, Xiao Z, Sun B, Wang Y, Zheng M, Ye L, Zhang X.

Biochem Biophys Res Commun. 2014 Mar 14;445(3):651-5. doi: 10.1016/j.bbrc.2014.02.068. Epub 2014 Feb 24.

PMID:
24576478
3.

Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway.

Cui M, Xiao Z, Wang Y, Zheng M, Song T, Cai X, Sun B, Ye L, Zhang X.

Cancer Res. 2015 Mar 1;75(5):846-57. doi: 10.1158/0008-5472.CAN-14-1192. Epub 2015 Jan 15.

4.

Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT.

Liu F, You X, Chi X, Wang T, Ye L, Niu J, Zhang X.

Biochem Biophys Res Commun. 2014 Feb 7;444(2):128-34. doi: 10.1016/j.bbrc.2014.01.004. Epub 2014 Jan 14.

PMID:
24434140
5.

Aspirin suppresses the abnormal lipid metabolism in liver cancer cells via disrupting an NFκB-ACSL1 signaling.

Yang G, Wang Y, Feng J, Liu Y, Wang T, Zhao M, Ye L, Zhang X.

Biochem Biophys Res Commun. 2017 May 6;486(3):827-832. doi: 10.1016/j.bbrc.2017.03.139. Epub 2017 Mar 27.

PMID:
28359761
6.

Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model.

Kong G, Zhang J, Zhang S, Shan C, Ye L, Zhang X.

PLoS One. 2011 May 5;6(5):e19518. doi: 10.1371/journal.pone.0019518.

7.

Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.

Zhang T, Zhang J, Cui M, Liu F, You X, Du Y, Gao Y, Zhang S, Lu Z, Ye L, Zhang X.

Neoplasia. 2013 Nov;15(11):1282-91.

8.

MiR-506 suppresses liver cancer angiogenesis through targeting sphingosine kinase 1 (SPHK1) mRNA.

Lu Z, Zhang W, Gao S, Jiang Q, Xiao Z, Ye L, Zhang X.

Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):8-13. doi: 10.1016/j.bbrc.2015.11.008. Epub 2015 Nov 6.

PMID:
26549227
9.

Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.

Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.

Oncotarget. 2015 Nov 10;6(35):38093-106. doi: 10.18632/oncotarget.5642.

10.

miR-202 suppresses cell proliferation in human hepatocellular carcinoma by downregulating LRP6 post-transcriptionally.

Zhang Y, Zheng D, Xiong Y, Xue C, Chen G, Yan B, Ye Q.

FEBS Lett. 2014 May 21;588(10):1913-20. doi: 10.1016/j.febslet.2014.03.030. Epub 2014 Apr 3.

11.

Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.

Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB, Chen Y.

Eur J Cancer. 2014 Oct;50(15):2560-9. doi: 10.1016/j.ejca.2014.07.008. Epub 2014 Jul 30.

PMID:
25087183
12.

MiR-520b suppresses proliferation of hepatoma cells through targeting ten-eleven translocation 1 (TET1) mRNA.

Zhang W, Lu Z, Gao Y, Ye L, Song T, Zhang X.

Biochem Biophys Res Commun. 2015 May 8;460(3):793-8. doi: 10.1016/j.bbrc.2015.03.108. Epub 2015 Mar 28.

PMID:
25824049
13.

MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3'UTR.

Wang Y, Chen F, Zhao M, Yang Z, Zhang S, Ye L, Gao H, Zhang X.

Biochem Biophys Res Commun. 2016 Nov 18;480(3):455-460. doi: 10.1016/j.bbrc.2016.10.070. Epub 2016 Oct 20.

PMID:
27773820
14.

Epigenetic repression of miR-132 expression by the hepatitis B virus x protein in hepatitis B virus-related hepatocellular carcinoma.

Wei X, Tan C, Tang C, Ren G, Xiang T, Qiu Z, Liu R, Wu Z.

Cell Signal. 2013 May;25(5):1037-43. doi: 10.1016/j.cellsig.2013.01.019. Epub 2013 Jan 30.

PMID:
23376496
15.

HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma.

Qiu X, Dong S, Qiao F, Lu S, Song Y, Lao Y, Li Y, Zeng T, Hu J, Zhang L, Zhang L, Fan H.

Oncogene. 2013 Jul 4;32(27):3296-305. doi: 10.1038/onc.2013.150. Epub 2013 Apr 22.

PMID:
23604124
16.

Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo.

Parkes HA, Preston E, Wilks D, Ballesteros M, Carpenter L, Wood L, Kraegen EW, Furler SM, Cooney GJ.

Am J Physiol Endocrinol Metab. 2006 Oct;291(4):E737-44. Epub 2006 May 16.

PMID:
16705061
17.

Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells.

Chen F, Zhu HH, Zhou LF, Wu SS, Wang J, Chen Z.

Oncol Rep. 2010 May;23(5):1457-62.

PMID:
20372864
18.

Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells.

You X, Liu F, Zhang T, Li Y, Ye L, Zhang X.

Carcinogenesis. 2013 Jul;34(7):1644-52. doi: 10.1093/carcin/bgt089. Epub 2013 Mar 7.

PMID:
23471881
19.

Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP.

Zhang W, Lu Z, Kong G, Gao Y, Wang T, Wang Q, Cai N, Wang H, Liu F, Ye L, Zhang X.

Mol Cancer. 2014 May 28;13:128. doi: 10.1186/1476-4598-13-128.

20.

Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells.

Zhang T, Zhang J, You X, Liu Q, Du Y, Gao Y, Shan C, Kong G, Wang Y, Yang X, Ye L, Zhang X.

Hepatology. 2012 Dec;56(6):2051-9. doi: 10.1002/hep.25899. Epub 2012 Nov 13.

PMID:
22707013

Supplemental Content

Support Center